Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Autor: Van Hoof, Achiel, Sheliga, Adriana, Teixeira, Adriana, Tomita, Akihiro, Rocafiguera, Albert Oriol, Suvorov, Alexander, Kuzmin, Alexy, Khojasteh, Ali, Mezlini, Amel, Golenkov, Anatoly, Bosly, Andre, Belch, Andrew, Van De Velde, Ann, Illes, Árpád, Mukhopadhyay, Ashis, Meddeb, Balkis, De Prijck, Bernard, Garichochea, Bernardo, Undar, Bulent, Gabarrón, Caballero, Cao, Carmen, Souza, Carmino, Farber, Charles, Won Suh, Cheol, Burcoveanu, Cristina Ileana, Cebotaru, Cristina Ligia, Truica, Cristina-Ligia, Maruyama, Dai, Belada, David, Ben Yehuda, Dina, Udovitsa, Dmitry, Dolores, Morra, Enrica, Späth-Schwalbe, Ernst, Gonzalez-Barca, Eva, Osmanov, Evgenii, Capote, Francisco Javier, Offner, Fritz, Cardenas, Galvez, Heß, Georg, Manikhas, Georgii, Babu, Govind, Rekhtman, Grigoriy, Rossi, Guiseppe, Marques, Herlander, Bumbea, Horia, Wang, Huaqing, Huang, Huiqiang, Choi, Ilseung, Bulavina, Irina, Lysenko, Irina, Avivi, Irit, Kryachok, Iryna, Zaucha, Jan Maciej, Novak, Jan, Díaz, Joaquín, Demeter, Judit, Alexeeva, Julia, Zhu, Jun, Vilchevskaya, Kateryna, Ishizawa, Kenichi, Mauricio, Kenny, Tobinai, Kensei, Ando, Kiyoshi, Abdulkadryrov, Kudrat, Shih, Lee-Yung, Kuzina, Lyudmila, Gumus, Mahmut, De Wit, Maike, Capra, Marcelo, Marques, Margarida, Golubeva, Marina, Ojeda-Uribe, Mario, Kyselyova, Maryna, Taniwaki, Masafumi, Federico, Massimo, Crump, Michael, Baccarani, Michele, Ogura, Michinori, Egyed, Miklós, Udvardy, Miklos, Kurosawa, Mitsutoshi, Uike, Naokuni, Khuageva, Nuriet, Shpilberg, Ofer, Gladkov, Oleg, Samoilova, Olga, Serduk, Olga, Santi, Patricia, Zachee, Pierre, Kaplan, Polina, Stoia, Razvan, Gressin, Remy, Arranz, Reyes, Greil, Richard, Grosicki, Sebastian, Cancelado, Sergio, Nair, Sreejith, Le Gouill, Steven, Van Steenweghen, Steven, Yoon, Sung-Soo, Chuncharune, Suporn, Scheider, Tatiana, Shimoyama, Tatsu, Liu, Ting, Kinoshita, Tomohiro, Uchida, Toshiki, Bunworasate, Udomsak, Vitolo, Umberto, Pavlov, Viacheslav, Phooshkooru, Vijay Rao, Lima, Vladimir, Merkulov, Vladimir, Nawarawong, Weerasak, Hong, Xiaonan, Ke, Xiaoyan, Terui, Yasuhito, Tee Goh, Yeow, Maeda, Yoshiharu, Shi, Yuankai, Dunaev, Yuri, Lorie, Yurii, Wang, Zhao, Shen, Zhixiang, Borbenyi, Zita, Gasztonyi, Zoltán, Masliak, Zvenyslava, Robak, Tadeusz, Jin, Jie, Pylypenko, Halyna, Verhoef, Gregor, Siritanaratkul, Noppadol, Drach, Johannes, Raderer, Markus, Mayer, Jiri, Pereira, Juliana, Tumyan, Gayane, Okamoto, Rumiko, Nakahara, Susumu, Hu, Peter, Appiani, Carlos, Nemat, Sepideh, Cavalli, Franco

Publikováno v: In The Lancet Oncology November 2018 19(11):1449-1458

[Untitled]

Autor: Lysenko , Irina A.

The stationary rotation of a system of N point vortices (N=3, 4,5) with identical intensities for the Alfven model of two-fluid plasma is considered. The equations of motion are Hamiltonian. The stability of stationary rotation for a system of 3, 4,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4690f95ea6a185992581632c1d885b5a

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Untitled]

Autor: Zolotareva , Ekaterina I., Бондаренко , Elena S., Vladimirova , Liubov Yu., Nepomnyashchaya , Evgenia M., Novikova , Inna A., Ulianova , Elena P., Zlatnik , Elena Yu., Shulgina , Oksana G., Lysenko , Irina B., Grankina , Anastasia O.

The article presents the results of two series of experimental studies on the effect of cytokine immunomodulators (Ingaron, Refnot and Roncoleukin) and cytostatics (Doxorubicin) on the growth of transplantable B16 melanoma. The experiment included C5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::340f7e81f1693311e1b338e2ddf91aab

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.